Analyst firms · Stifel · IDYA

Stifel IDYA price target and rating history

IDEAYA Biosciences Inc. (IDYA) · Health Care

Stifel rates IDEAYA Biosciences Inc. (IDYA) Buy with a $48 price target, as of its latest action on Oct 14, 2026. It has published 5 rating actions on IDYA since September 2021, including 2 upgrades and 1 downgrade.

Current rating

Buy

Price target

$48

Median target, all firms

Too few

Actions on IDYA

5

Stifel price target on IDYA

Every Stifel rating on IDYA

• Oct 14, 2026
  ResumeStifel resumes coverage at Buy, price target $48
• Apr 24, 2023
  UpgradeStifel upgrades to Buy from Hold, price target $18 to $24
• Aug 15, 2022
  DowngradeStifel downgrades to Hold from Buy, price target $16 to $13
• Mar 10, 2022
  UpgradeStifel upgrades to Buy from Hold, price target $27 to $20
• Sep 23, 2021
  InitiateStifel starts coverage at Hold, price target $27

How other firms rate IDYA

Each firm's latest rating and stated target in the last 12 months.

Questions about Stifel and IDYA

What is Stifel's price target for IDYA?

Stifel's latest stated price target for IDEAYA Biosciences Inc. (IDYA) is $48, from its action on Oct 14, 2026.

What is Stifel's rating on IDYA?

Stifel rates IDYA Buy, a bullish rating, as of Oct 14, 2026.

When did Stifel last change its view on IDYA?

On Oct 14, 2026, Stifel resumes coverage at Buy, price target $48.

All Stifel ratingsIDYA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.